Hillsborough, NJ, United States of America

Feng Qian

This inventor holds 3 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2009-2011.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 15.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Feng Qian

Introduction

Feng Qian is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel pharmaceutical compounds. With a total of 3 patents to his name, his work has the potential to impact various therapeutic areas.

Latest Patents

Feng Qian's latest patents include a process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein. This innovative process provides a method for synthesizing triazole substituted azaindoleoxoacetic piperazine derivatives. Additionally, it introduces novel intermediates and new forms of these compounds, which could lead to advancements in drug development.

Career Highlights

Throughout his career, Feng Qian has worked with prominent companies such as Bristol-Myers Squibb Company and Bristol-Myers Squibb Holdings Ireland. His experience in these organizations has allowed him to refine his skills and contribute to significant projects in the pharmaceutical industry.

Collaborations

Feng Qian has collaborated with talented individuals in his field, including Nachimuthu Soundararajan and Yuping Qiu. These partnerships have fostered innovation and have been instrumental in the development of his patented processes.

Conclusion

Feng Qian's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…